Skip to main content
SpringerLink
Log in

Evaluation of blood plasma changes by differential scanning calorimetry in psoriatic patients treated with drugs

  • Published:
Journal of Thermal Analysis and Calorimetry Aims and scope Submit manuscript

Abstract

Psoriasis is a chronic inflammatory skin disease, most commonly resulting in the occurrence of red and silver scaly plaques. Application of differential scanning calorimetry (DSC) should be used as a new method to detect the different stages of the disease and to monitor medications with different anti-psoriatic drugs using patient’s blood plasma. The study included 72 white adults (35 men and 37 women; median age 56 years) with diagnosed psoriasis. According to the psoriasis area severity index (PASI) patients were selected into three groups: symptomless (PASI: 0), mild (PASI: 1–15), and serious symptoms (PASI: >15). According to medication patients were divided into untreated (n = 39) and treated (n = 33) groups. For systemic drug treatment cytostatic therapy (methotrexate, n = 12), retinoid treatment (acitretin, n = 10), and biologic response modifiers (adalimumab, n = 5; infliximab, n = 5; ustekinumab, n = 1) were applied. Denaturation of human plasma components were detected in Setaram Micro DSC II calorimeter. The patients had no third denaturation peak in the untreated mild and serious symptoms groups. In mild symptoms all the thermal parameters altered significantly, while in serious symptoms only the first melting and the calorimetric enthalpy altered significantly compared with symptoms-free states. In case of systematic cytostatic and retinoid drug treatment (methotrexate, n = 12; acitretin, n = 10) cases the DSC scans of patients with symptoms exhibited significant differences (p < 0.05) in melting temperatures and in calorimetric enthalpy compared with the untreated symptoms-free patients. Using biologic response modifier agents (adalimumab, infliximab, and ustekinumab) we had no enough samples for a statistical evaluation for each one, but after the intervention a stronger effect can be seen as in case of systematic drug treatment. In this study blood plasma measurement in psoriatic patients by DSC showed differences between untreated, conventional systemic drug treatment, and application of biologic response modifier agents, but further studies are needed to elucidate these relationships (supported by grant OTKA CO-272).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445:866–73.

    Article  CAS  Google Scholar 

  2. Oka A, Mabuchi T, Ozawa A, Inoko H. Current understanding of human genetics and genetic analysis of psoriasis. J Dermatol. 2012;39:231–41.

    Article  CAS  Google Scholar 

  3. Palfreeman AC, McNamee KE, McCann FE. New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast. Drug Des Dev Ther. 2013;7:201–10.

    Article  CAS  Google Scholar 

  4. Mabuchi T, Yamaoka H, Kojima T, Ikoma N, Akasaka E, Ozawa A. Psoriasis affects patient’s quality of life more seriously in female than in male in Japan. Tokai J Exp Clin Med. 2012;37:84–8.

    Google Scholar 

  5. Moezzi M, Fekecs T, Zapf I, Ferencz A, Lőrinczy D. Differential scanning calorimetry (DSC) analysis of human plasma in different psoriasis stages. J Therm Anal Calorim. 2013;111:1801–4.

    Article  CAS  Google Scholar 

  6. Michnik A, Drzazga Z, Michalik K, Barczyk A, Santura I, Sozańska E, Pierzchała W. Differential scanning calorimetry study of blood serum in chronic obstructive pulmonary disease. J Therm Anal Calorim. 2010;102:57–60.

    Article  CAS  Google Scholar 

  7. Todinova S, Krumova S, Kurtev P, Dimitrov V, Djongov L, Dudunkov Z, Taneva SG. Calorimetry-based profiling of blood plasma from colorectal cancer patients. Biochim Biophys Acta. 2012;1820:1879–85.

    Article  CAS  Google Scholar 

  8. Michnik A, Drzazga Z. Thermal denaturation of mixtures of human serum proteins. J Therm Anal Calorim. 2012;101:513–8.

    Article  CAS  Google Scholar 

  9. Todinova S, Krumova S, Gartcheva L, Robeerst C, Taneva SG. Microcalorimetry of blood serum proteome: a modified interaction network int he multiple myeloma case. Anal Chem. 2011;83:7992–8.

    Article  CAS  Google Scholar 

  10. Zapf I, Fekecs T, Ferencz A, Tizedes Gy, Pavlovics G, Kálmán E, Lőrinczy D. DSC analysis of human plasma in breast cancer patients. Thermochim Acta. 2011;524:88–91.

    Article  CAS  Google Scholar 

  11. Fish DJ, Brewood GP, Kim JS, Garbett NC, Chaires JB, Benight AS. Statistical analysis of plasma thermograms measured by differential scanning calorimetry. Biophys Chem. 2010;152:184–90.

    Article  CAS  Google Scholar 

  12. Garbett NC, Mekmaysy CS, Helm CW, Jenson AB, Chaires JB. Differential scanning calorimetry of blood plasma for clinical diagnosis and monitoring. Exp Mol Pathol. 2009;86:186–91.

    Article  CAS  Google Scholar 

  13. Committee For Medicinal Products For Human Use. Guideline on clinical investigation of medicinal products indicated for the treatment of psoriasis. London, 2004, CHMP/EWP/2454/02.

  14. Dubois DS, Pouliot R. Promising new treatments for psoriasis. Sci World J. 2013. doi: 10.1155/2013/980419.

  15. Weigle N, McBane S. Psoriasis. Am Fam Physician. 2013;87:626–33.

  16. Di Meglio P, Perera GK, Nestle FO. The multitasking organ: recent insights into skin immune function. Immunity. 2011;35:857–69.

    Article  CAS  Google Scholar 

  17. Kotnik V. Complement in skin diseases. Acta Dermatovenerol Alp Panonica Adriat. 2011;20:3–11.

    CAS  Google Scholar 

  18. Johnson-Huang LM, Lowes MA, Krueger JG. Putting together the psoriasis puzzle: an update on developing targeted therapies. Dis Model Mech. 2012;5:423–33.

    Article  CAS  Google Scholar 

  19. Staidle JP, Dabade TS, Feldman SR. A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency. Expert Opin Pharmacother. 2011;12:2041–54.

    Article  Google Scholar 

  20. Barker J, Horn EJ, Lebwohl M, Warren RB, Nast A, Rosenberg W, Smith C, International Psoriasis Council. Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic. J Eur Acad Dermatol Venereol. 2011;25:758–64.

    Article  CAS  Google Scholar 

  21. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009;61:451–85.

    Article  CAS  Google Scholar 

  22. Bruylants G, Wouters J, Michaux C. Differential scanning calorimetry in life science: thermodynamics, stability, molecular recognition and application in drug design. Curr Med Chem. 2005;12:2011–20.

    Article  CAS  Google Scholar 

  23. Ahn CS, Gustafson CJ, Sandoval LF, Davis SA, Feldman SR. Cost effectiveness of biologic therapies for plaque psoriasis. Am J Clin Dermatol. 2013;14:315–26.

    Article  Google Scholar 

  24. Lee JH, Cho JH, Yeo J, Lee SH, Yang SH, Sung YC, Kang JH, Park CS. The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein. Biologicals. 2013;41:77–83.

    Article  CAS  Google Scholar 

  25. Klotz U, Teml A, Schwab M. Clinical pharmacokinetics and use of infliximab. Clin Pharmacokinet. 2007;46:645–60.

    Article  CAS  Google Scholar 

  26. Tabrizi M, Bornstein GG, Suria H. Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease. AAPS J. 2010;12:33–43.

    Article  CAS  Google Scholar 

  27. Tabrizi MA, Bornstein GG, Klakamp SL, Drake A, Knight R, Roskos L. Translational strategies for development of monoclonal antibodies from discovery to the clinic. Drug Discov Today. 2009;14:298–305.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by Grants OTKA CO-272 (for Dénes Lőrinczy).

Author information

Authors and Affiliations

  1. Department of Dermatology, Venereology and Oncodermatology, Medical School, University of Pécs, Kodály Z. Str. 20, Pecs, 7624, Hungary

    Medhi Moezzi

  2. Department of Surgical Research and Techniques, Medical Faculty, Semmelweis University, Nagyvárad Sqr. 4, Budapest, 1089, Hungary

    Andrea Ferencz

  3. Institute of Biophysics, Medical School, University of Pécs, Szigeti Str. 12, Pecs, 7624, Hungary

    Dénes Lőrinczy

Authors
  1. Medhi Moezzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Ferencz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dénes Lőrinczy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dénes Lőrinczy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moezzi, M., Ferencz, A. & Lőrinczy, D. Evaluation of blood plasma changes by differential scanning calorimetry in psoriatic patients treated with drugs. J Therm Anal Calorim 116, 557–562 (2014). https://doi.org/10.1007/s10973-013-3585-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10973-013-3585-2

Keywords

Search

Navigation